We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Buy OncoImmune and Potential Coronavirus Drug for $425 Million
Merck to Buy OncoImmune and Potential Coronavirus Drug for $425 Million
Merck is expanding further into the biotech sector by acquiring Rockville, Md., biopharma company OncoImmune for $425 million, netting in the process an investigational drug that has shown promise as a treatment for hospitalized COVID-19 patients.